EUCTR2009-015903-22-GB进行中（未招募）1 期
THE EFFECT OF EICOSAPENTAENOIC ACID (EPA) ON BIOMARKERS OF GROWTH AND VASCULARITY IN HUMAN COLORECTAL CANCER LIVER METASTASES - The Effects of EPA on Human Colorectal Cancer Liver Metastases
niversity of Leeds0 个研究点目标入组 88 人开始时间: 2010年6月28日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Age >18 years
- •Presence of colorectal cancer liver metastasis(es) deemed appropriate for liver resection
- •Duration between decision to perform liver resection and surgery >2 weeks
- •Ability to give written informed consent and follow study protocol
- •Telephone contact possible
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Neo-adjuvant chemotherapy for CRC liver metastasis
- •Chemotherapy for any cancer in the previous 3 months
- •Known bleeding diathesis or anticoagulation therapy
- •Fish or seafood allergy
- •Use of fish oil supplements (eg. cod liver oil) and unwilling to stop for the duration of the study
- •Corticosteroid or non-steroidal anti-inflammatory (NSAID) use (except low dose aspirin)
- •Renal impairment (serum creatanine >150micromol/l)
- •Active inflammatory disease (e.g. Inflammatory Bowel Disease, Rheumatoid Arthritis)
研究者
相似试验
已完成
2 期
Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver MetastasesColorectal CancerNCT01070355University of Leeds88
尚未招募
3 期
Analysis for effect of Eicosapentaenoic acid (EPA) on aberrant crypt foci (ACF)Subjects with aberrant crypt foci (ACF)JPRN-UMIN000001551Gastroenterology Division, Yokohama City University Graduate School of Medicine100
招募中
不适用
A study on the effects of eicosapentaenoic acid (EPA) on arteriosclerosis in hemodialysis patients with percutaneous coronary intervention (PCI)Dialysis patients who have been subjected to PCI.JPRN-UMIN000002653agoya Kyoritsu Hospital100
已完成
不适用
Evaluation of the impact of eicosapentaenoic acid on postprandial hyperglycemia, hyperliopemia and endothelial dysfunction in mild diabetic and impaired glucose tolerance patients with coronary artery disease.untreated mild diabetic patients (HbA1c<7.0%) and impaired glucose tolearenceJPRN-UMIN000011265Hyogo Brain and Heart Center80
已完成
3 期
Comparison of effects of EPA and DHA in patients with type 2 diabetesDiabetes Mellitus 2.Non-insulin-dependent diabetes mellitusIRCT138812102394N4Vice-chancellor for research, Tehran University of Medical Sciences60